Want to see IN:JUBLINGREA full AI Analyst Report?
JUBLINGREA Stock Chart & Stats
₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)
Day’s Range― - ―
52-Week Range₹535.30 - ₹794.95
Previous CloseN/A
Volume517.05K
Average Volume (3M)23.80K
Market Cap
₹90.46B
Enterprise Value₹110.11B
Total Cash (Recent Filing)₹2.42B
Total Debt (Recent Filing)₹8.95B
Price to Earnings (P/E)25.6
Beta1.24
Next Earnings
Feb 02, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.88%
Share Statistics
EPS (TTM)22.21
Shares Outstanding159,281,140
10 Day Avg. Volume18,124
30 Day Avg. Volume23,795
Financial Highlights & Ratios
PEG Ratio2.89
Price to Book (P/B)2.75
Price to Sales (P/S)1.96
P/FCF Ratio52.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)26.17
Revenue Forecast (FY)₹54.42B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthPositive revenue growth indicates that the company continues to expand its sales base across specialty chemicals and life-science ingredients. Sustained growth can improve operating scale, support customer retention, and provide a foundation for stronger earnings over the next several quarters.
Earnings GrowthEPS growth is a constructive sign that recent business performance is translating into higher earnings per share. If supported by continued product demand and disciplined operations, this can strengthen internal funding capacity and reinforce the company’s competitive position.
Manageable LeverageLeverage remains manageable despite increasing from earlier years, giving Jubilant Ingrevia a relatively resilient balance-sheet base. This supports continued investment in specialty chemicals and ingredients while preserving more financial flexibility than a highly levered structure would allow.
Bears Say
Weak Cash ConversionWeak conversion of accounting earnings into operating cash reduces the quality and reliability of reported profitability. It can constrain internally funded investment, make working-capital demands more important, and leave the company less flexible when cash requirements increase.
Volatile Free Cash FlowVolatile free cash flow makes the company’s ability to fund expansion, debt service, and shareholder returns less predictable. Although free cash flow turned positive recently, the latest decline and prior negative years indicate that cash generation may not consistently track operating earnings.
Lower Margins And ReturnsProfitability remains positive but is below the stronger FY2022 cycle, while gross-margin volatility signals an inconsistent cost and pricing environment. Lower margins and weaker return on equity can limit reinvestment efficiency and make earnings more sensitive to operating conditions.
Jubilant Ingrevia Ltd. News
JUBLINGREA FAQ
What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹794.95 in the past 12 months.
What is Jubilant Ingrevia Ltd.’s market cap?
Jubilant Ingrevia Ltd.’s market cap is ₹90.46B.
When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
Jubilant Ingrevia Ltd.’s upcoming earnings report date is Feb 02, 2027 which is in 95 days.
How were Jubilant Ingrevia Ltd.’s earnings last quarter?
Jubilant Ingrevia Ltd. released its earnings results on Oct 27, 2026. The company reported ₹7.1 earnings per share for the quarter, beating the consensus estimate of ₹6.7 by ₹0.4.
Is Jubilant Ingrevia Ltd. overvalued?
According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued.
Does Jubilant Ingrevia Ltd. pay dividends?
Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.88%. See more information on Jubilant Ingrevia Ltd. dividends here
What is Jubilant Ingrevia Ltd.’s EPS estimate?
Jubilant Ingrevia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jubilant Ingrevia Ltd. have?
Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
Jubilant Ingrevia Ltd. reported an EPS of ₹7.1 in its last earnings report, beating expectations of ₹6.7. Following the earnings report the stock price went up 4.052%.
Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
Currently, no hedge funds are holding shares in IN:JUBLINGREA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jubilant Ingrevia Ltd.
Jubilant Ingrevia Limited, established in 2019 and based in Noida, India, is a global supplier of life science products and comprehensive solutions. The company's operations are divided into three core divisions: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment delivers a variety of specialized ingredients, fine chemicals, and crop protection agents, in addition to offering custom development and manufacturing (CDMO) services. Its Nutrition & Health Solutions division focuses on ingredients for both human and animal nutrition and well-being. Meanwhile, the Life Science Chemicals segment provides crucial life science components and a range of specialized ethanol products. Jubilant Ingrevia's extensive portfolio encompasses numerous chemical offerings, including a broad spectrum of pyridine derivatives (such as picolines, cyanopyridines, and various substituted pyridines), essential vitamins like B3 and riboflavin phosphate sodium, and nutritional compounds like premixes and antioxidants. They also produce industrial chemicals like acetic anhydride, ethyl acetate, and various alcohols (absolute alcohol, ethanol), alongside biocompost and gas mixtures. Furthermore, the company supplies a wide array of animal health and nutrition additives, including mineral premixes, stress regulators, amino acids, herbal growth promoters, toxin binders, and enzymes. Beyond its product range, Jubilant Ingrevia offers specialized services in chemical synthesis, covering everything from initial route design and process optimization to scaling up production and commercial manufacturing of intermediates. The company serves a diverse client base across the pharmaceutical, nutrition, agrochemical, consumer goods, and industrial sectors. Originally incorporated as Jubilant LSI Limited, the company adopted its current name, Jubilant Ingrevia Limited, in October 2020.
Technical Analysis
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Piramal Pharma Limited
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―








